Human Papilloma Virus and Vaccination in the Andean Region (original) (raw)

This book chapter presents human papillomavirus (HPV) and HPV-attributable disease epidemiology, attitudes towards HPV and HPV-attributable diseases, as well as successful school-based and combined clinic-and school-based HPV vaccination programs, in the Latin American Andean region. Despite only 16% of incident cervical cancer cases occurring in the Latin American Countries (LAC) of the Caribbean, Central and South America, LAC have a 38% cervical cancer mortality. School-based HPV vaccination programs in LMIC have achieved herd-immunity sustaining 3-dose vaccination rates greater than 80%. However, 2-dose HPV vaccination programs for under 15-years-old should be more cost effective than 3-dose HPV vaccination programs, while also satisfying WHO vaccination program requirements. Irrespective of affordability, HPV vaccination acceptance is needed for successful HPV vaccination programs. Lack of HPV knowledge and HPV vaccination misinformation provide a basis upon which targeted HPV awareness and preventive health media campaigns can be developed. Optimally, media campaigns should use the internet, radio, and television to address health care providers, parents, and students. Clinics may use additional counseling materials in-house with their clients. Ministries of Education, Finance, and Health cosponsoring HPV vaccination programs can increase national HPV, HPV-related diseases, and HPV vaccination awareness.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact